The structure of IGF-I is similar to that of insulin, having 43 % sequence homology with human proinsulin. Both peptides can induce metabolic and mitogenic effects through their own specific receptors, which also share many structural and functional similarities. Primarily involved in the regulation
The Insulin-like Growth Factor System: a Key Determinant Role in the Growth and Selection of Ovarian Follicles? A Comparative Species Study
✍ Scribed by S Mazerbourg; CA Bondy; J Zhou; P Monget
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 261 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0936-6768
No coin nor oath required. For personal study only.
✦ Synopsis
Contents
The aim of the present paper is to make a comparative study of the expression of the elements of the insulin‐like growth factor (IGF) system in different mammalian species and thus illuminate their potential role in the process of ovarian folliculogenesis in mammals. In most mammalian species, IGFs and IGFBPs (in particular IGFBP‐2 and IGFBP‐4) are considered, respectively, as stimulators and inhibitors of follicular growth and maturation. In mammalian species, IGFs might play a key role in sensitizing ovarian granulosa cells to FSH action during terminal follicular growth. Concentrations of IGFBP‐2 and IGFBP‐4 in follicular fluid strongly decrease and increase during follicular growth and atresia, respectively, leading to an increase and a decrease in IGF bioavailability, respectively. The decrease in these IGFBPs is because of a decrease in mRNA expression (IGFBP‐2) and an increase in proteolytic degradation by PAPP‐A in follicular fluid (IGFBP‐2, IGFBP‐4 and IGFBP‐5), and likely participates in the selection of dominant follicles. In contrast, levels and/or sites of expression of IGF‐I, IGF‐II, IGFBP‐4, IGFBP‐5 and type II receptor in follicular cells strongly differ between mammalian species, suggesting that these phenomena might play species‐specific or secondary roles in ovarian folliculogenesis.
📜 SIMILAR VOLUMES
## Abstract Insulin‐like growth factor‐binding proteins (IGF‐BPs) were demonstrated in the circulation of four teleost fish species. In the coho salmon (__Oncorhynchus kisutch__), serum binding of ^125^I‐labelled human IGF‐I (^125^I‐hIGF‐I) was competitively inhibited by addition of excess recombin
## Abstract ## Background Epidemiological studies have linked obesity with many cancers. The insulin-like growth factor (IGF) 1 axis may be an important mediator in obesity-associated cancer. This study examined the relationship between IGF-1 and its receptor (IGF-1R) in oesophageal adenocarcinoma
## Abstract The physical inactivity and obesity involved in hyperglycemia and hyperinsulinemia is supposed to lead to an increased bioavailability of insulin‐like growth factor‐I (IGF‐I). The carcinogenic effect of IGF‐I may be influenced by IGF binding proteins. We investigated the association bet
## Abstract Insulin‐like growth factor‐1 (IGF‐1) is essential to hippocampal neurogenesis and the neuronal response to hypoxia/ischemia injury. IGF (IGF‐1 and ‐2) signaling is mediated primarily by the type 1 IGF receptor (IGF‐1R) and modulated by six high‐affinity binding proteins (IGFBP) and the
Insulin-like growth factor-I (IGF-I) plays a key role in normal development. Recent studies show that IGF-I exerts a wide variety actions in the central nervous system during development as well as in adulthood. This report reviews recent developments on IGF-I actions and its mechanisms in the centr